Claim: Hormone replacement therapy causes breast cancer in women

First requested: August 28, 2026 at 7:41 PM
67%

IsItCap Score

Truth Potential Meter

Moderately Credible

AI consensusWeak

Grader consensus is weak.
Range 50%–70% (spread Δ20).
The graders diverge. Treat the combined score as uncertain and read the sources carefully.
Read analysis summary

OpenAI Grade

0%
20%
40%
60%
80%
70%

Perplexity Grade

0%
20%
40%
60%
80%
68%

Google Gemini Grade

0%
20%
40%
60%
80%
50%
Shareable summary
Verdict: Questionable
  • Estrogen-only HRT is not consistently linked to higher risk.
  • Some reviews find little or no increase depending on type.
/r/hormone-replacement-therapy-breast-cancer-risk

Analysis Summary

Hormone replacement therapy (HRT) is mostly true to be associated with an increased risk of breast cancer in women, particularly with combined HRT. This view is supported by reputable sources like the NHS and BreastCancer.org, which highlight the slight increase in risk. However, some studies, including those from the NIH and PMC, argue that estrogen-only therapy may not increase risk and could even lower it, leading to disputes regarding the overall impact of HRT on breast cancer risk. Thus, while there is a consensus on the risks associated with combined HRT, the effects of estrogen-only therapy remain debated. The graders interpret the evidence differently, so the score range widens. OpenAI comes in highest (70%), while Gemini is lowest (50%). Perplexity expresses higher confidence than Gemini on this claim. While the majority of evidence suggests that hormone replacement therapy, particularly combined HRT, increases breast cancer risk, some sources argue against this claim. For instance, the NIH indicates that unopposed estrogen therapy may lower breast cancer incidence, and other studies suggest that estrogen-only therapy after hysterectomy could reduce risk. These conflicting findings highlight the complexity of HRT's effects on breast cancer risk and suggest that the relationship is not entirely straightforward, which does not change the overall verdict but indicates a nuanced understanding is necessary.

Source quality

Truth (from sources)7.00 / 10
Source reliability8.00 / 10
Source independence7.00 / 10

Claim checks

Fits established facts6.00 / 10
Logical consistency7.00 / 10
Expert consensus6.00 / 10

Source Analysis

Common arguments
Supporting the claim
  • Combined HRT is linked to a small risk increase.
  • Large observational studies found increased risk with most exposure.
  • Risk rises with longer use in some reports.
Against the claim
  • Estrogen-only HRT is not consistently linked to higher risk.
  • Some reviews find little or no increase depending on type.
  • Risk is not uniform across all HRT regimens.

Mainstream Sources

Publication

NHS

Title

Benefits and risks of hormone replacement therapy (HRT)

Summary

The NHS says HRT can slightly increase breast cancer risk, especially combined HRT used longer.

Source details

Publication

BreastCancer.org

Title

Hormone Replacement Therapy (HRT) and Breast Cancer Risk

Summary

This source says combined HRT can slightly increase breast cancer risk, while estrogen-only HRT is not linked to a higher risk.

Source details

Publication

BMJ

Title

Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases

Summary

This large observational study found that most HRT exposure was associated with an increased risk of breast cancer.

Source details

Alternative Sources

Publication

NIH

Title

Breast cancer risk in younger women may be influenced by hormone therapy

Summary

The NIH reports that unopposed estrogen therapy was linked to lower breast cancer incidence, while combined estrogen-plus-progestin therapy increased risk.

Source details

Publication

PMC

Title

Could Perimenopausal Estrogen Prevent Breast Cancer

Summary

This review says combined HRT increases risk, but estrogen-only therapy after hysterectomy may reduce breast cancer risk.

Source details

Publication

PMC

Title

Menopausal Hormone Therapy and the Breast

Summary

This review concludes HRT can cause little or no increase in breast cancer risk depending on type and duration.

Source details

Analysis Breakdown

True/False Spectrum (7.0)Source Credibility (8.0)Bias Assessment (7.0)Contextual Integrity (6.0)Content Coherence (7.0)Expert Consensus (6.0)68%

How to read the breakdown

Weakest areas
Context6.0/10Consensus6.0/10
  • Truth: how well sources support the core claim.
  • Source reliability: whether the sources have a strong track record.
  • Independence: whether coverage looks one-sided or recycled.
  • Context: missing details (timeframe, definitions, scope) that change meaning.
  • Tip: if graders disagree, rely more on the summary + sources than the single number.

Detailed AnalysisPremium Feature

Get an in-depth analysis of content accuracy, source credibility, potential biases, contextual factors, claim origins, and hidden perspectives.

Create a free account to unlock premium features.

Methodology